356 related articles for article (PubMed ID: 17048337)
21. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
22. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
23. Are older breast carcinoma survivors willing to take hormone replacement therapy?
Ganz PA; Greendale GA; Kahn B; O'Leary JF; Desmond KA
Cancer; 1999 Sep; 86(5):814-20. PubMed ID: 10463980
[TBL] [Abstract][Full Text] [Related]
24. Current trends in hormone replacement therapy.
Khashoggi TY
Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
[TBL] [Abstract][Full Text] [Related]
25. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
26. Approach to the patient with menopausal symptoms.
Martin KA; Manson JE
J Clin Endocrinol Metab; 2008 Dec; 93(12):4567-75. PubMed ID: 19056840
[TBL] [Abstract][Full Text] [Related]
27. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
28. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
[TBL] [Abstract][Full Text] [Related]
29. Lifestyle risk management--a qualitative analysis of women's descriptions of taking hormone therapy following surgically induced menopause.
Crowe M; Burrell B; Whitehead L
J Adv Nurs; 2012 Aug; 68(8):1814-23. PubMed ID: 22082259
[TBL] [Abstract][Full Text] [Related]
30. Hormone therapy for management of menopausal symptoms: understanding [corrected] breast cancer risk.
Files JA; Allen SV; Pruthi S
Minerva Ginecol; 2012 Jun; 64(3):223-30. PubMed ID: 22635017
[TBL] [Abstract][Full Text] [Related]
31. Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.
Anagnostis EA
J Pharm Pract; 2012 Jun; 25(3):324-30. PubMed ID: 22550160
[TBL] [Abstract][Full Text] [Related]
32. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
[TBL] [Abstract][Full Text] [Related]
33. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
34. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
[TBL] [Abstract][Full Text] [Related]
35. Options for hormone therapy in women who have had a hysterectomy.
Haney AF; Wild RA
Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
[TBL] [Abstract][Full Text] [Related]
36. Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
Skouby SO; Barlow D; Samsioe G; Gompel A; Pines A; Al-Azzawi F; Graziottin A; Hudita D; Rozenberg S;
Maturitas; 2004 May; 48(1):19-25. PubMed ID: 15223104
[TBL] [Abstract][Full Text] [Related]
37. The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy.
Manson JE
Metabolism; 2013 Jan; 62 Suppl 1():S15-9. PubMed ID: 23018143
[TBL] [Abstract][Full Text] [Related]
38. Compounded bioidentical menopausal hormone therapy.
;
Fertil Steril; 2012 Aug; 98(2):308-12. PubMed ID: 22831824
[TBL] [Abstract][Full Text] [Related]
39. WHI risks: any relevance to menopause management?
Burger HG
Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
[TBL] [Abstract][Full Text] [Related]
40. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes.
Bassuk SS; Manson JE
Ann Epidemiol; 2015 Mar; 25(3):193-200. PubMed ID: 25534509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
